- New National Health Strategy Targets Protection of Earmarked Funds
- Parirenyatwa Hospital Commissions New Heart Bypass Machine, Boosts Open Heart Surgery in Zimbabwe
- Zimbabwe Targets 70-Year Life Expectancy in Ambitious New Health Strategy
- Blood Group O in Zimbabwe: Why Hospitals Can Never Have Enough
- Vaccine Storage Temperature Guidelines: What Health Facilities Must Know
The Union Hands Over TB REACH Project To Ministry Of Health
By Staff Reporter The Union Zimbabwe Trust (UZT) with financial assistance from the Stop TB Partnership has handed over the TB REACH project recently completed, to the Ministry of Health and Child Care. In 2021, UZT was among recipients of the Stop TB Partnership Wave 9 funding awarded to 11 projects across eight countries, focusing
Read More
Incapacitated DR-TB Patients Bear The Brunt of Catastrophic Costs
Nqobizitha Nkomo and his wife from Insiza District in Matebeleland South, were both diagnosed of Drug Resistant Tuberculosis (DR-TB) about a year ago. Even though they say they are feeling better, Nkomo recounts how their situation almost reduced them to beggars of some sort in their quest to sustain their treatment and recovery journey. By
Read More
Shortened DR TB Treatment Offers Ray Of Hope For TB Patients
A Study by the International Union Against Tuberculosis and Lung Disease (The Union) shows long-term effectiveness for shortened DR-TB treatment regimen up to 24 months after treatment completion Results from a Union-led observational study (1) published in The Lancet’s EClinicalMedicine, show that a nine-month shortened treatment regimen for rifampicin-resistant tuberculosis (RR-TB) delivered to patients under
Read More
Zim Annual TB Incidence Falls By 8%
CASES of new Tuberculosis (TB) infections have declined by 8% at the back of improved access to TB screening treatment and care at community level. By Michael Gwarisa The incidence of tuberculosis (TB) is defined as the number of new TB cases in one year per 100,000 population whereas prevalence of tuberculosis is defined as
Read More
Drug Resistant TB Treatment Efforts Under Threat says MSF
By Michael Gwarisa Doctors Without Borders/Médecins Sans Frontières (MSF) says limited access to to new drug delamanid reduces promising treatment options available for those with drug-resistant tuberculosis. According to MSF, almost three quarters (74%) of patients receiving a combination of these drugs for six months achieved ‘culture conversion’, an early indicator that treatment might ultimately be
Read More